The Foundation Fighting Blindness, Inc. invested in Sparing Vision
Jul 14, 2017 - RelSci Data Update
Investments

Background Information:
The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD.
In The News:
Foundation Fighting Blindness Clinical Research Institute Hosted Workshop for ProgStar, the Largest Natural History Study for Stargardt Disease Ever Launched
June 15, 2018  •  PR Newswire
Foundation Fighting Blindness and CheckedUpĀ® Partner to Educate Retinal-Disease Patients About Research, Resources, and Emerging Therapies During Doctor Visits
June 11, 2018  •  PR Newswire
CheckedUp Announces Initiative with the Foundation Fighting Blindness to Raise Awareness of Retinal Diseases
June 5, 2018  •  Business Wire
The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD.
SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.
In The News:
SparingVision to Present the Progress regarding Retinitis Pigmentosa's Treatment during the Annual Congress of Association for Research in Vision and Ophthalmology (ARVO)
May 2, 2018  •  Business Wire
SparingVision Participated in the 10th Annual Biotech Showcase
January 12, 2018  •  GlobeNewswire
SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.